2:2 degree (or international equivalent).
Months of entry
The biggest modern breakthrough for cancer treatment has been antibody therapies. An increasing number of biotechnology companies have antibody - or vaccine-based cancer therapies in development. This course aims to attract students interested in tumour immunology who wish to pursue a career either in industry (biotechnology) or academia.
Qualification, course duration and attendance options
- full time12 months
- Campus-based learningis available for this qualification
Course contact details
- Postgraduate Enquiries
- +44 (0) 115 951 5559